ABSTRACT
BACKGROUND: Anticoagulation therapy, especially using heparin or recently developed oral direct factor Xa inhibitors (DiXals), is recommended as first-line treatment for cancer-related venous thromboembolism (VTE). However, the preventive efficacy of these anticoagulants for cancer-associated ischemic stroke is still unknown. We retrospectively investigated the efficacy of subcutaneous unfractionated heparin (UFH) and DiXals for preventing the recurrence of cancer-associated cryptogenic ischemic stroke with VTE. METHODS: We retrospectively studied consecutive patients with cancer-associated cryptogenic ischemic stroke and comorbid VTE who received subcutaneous UFH or oral DiXaIs at 9 hospitals. RESULT: Fifty-three patients (24 treated with UFH and 29 treated with DiXaIs) were enrolled. Of these, 47 demonstrated systemic metastasis (cancer stage IV). During 30-day follow-up after initiation of anticoagulation therapy, recurrent ischemic stroke was observed in only 1 patient (4%) in the UFH group and in 9 patients (31%) in the DiXal group. The incidence of major bleeding complications was similar between the 2 groups (4% and 10%, respectively). The cumulative risk of ischemic stroke recurrence within 30 days was lower with UFH than with DiXals (competing risk analysis, p = 0.008). In the DiXal group, patients who experienced recurrence showed significantly higher D-dimer levels than those without recurrence. CONCLUSION: In patients with cancer-associated cryptogenic ischemic stroke and comorbid VTE, UFH demonstrated a lower rate of recurrent ischemic stroke than DiXaIs, and there were no differences in bleeding risk between the 2 treatments. D-dimer levels at stroke onset increased the risk of recurrence in the DiXal group but not in the UFH group.
Subject(s)
Brain Ischemia , Ischemic Stroke , Neoplasms , Stroke , Venous Thromboembolism , Anticoagulants/therapeutic use , Brain Ischemia/complications , Brain Ischemia/drug therapy , Factor Xa Inhibitors/therapeutic use , Heparin/therapeutic use , Heparin, Low-Molecular-Weight , Humans , Neoplasms/complications , Retrospective Studies , Stroke/drug therapy , Stroke/etiology , Venous Thromboembolism/drug therapy , Venous Thromboembolism/etiologyABSTRACT
A 32-year-old Japanese woman with headache, anorexia and malaise, just after travelling cities of the altitude of over 4,000 m by a long-distance coach is described. Her magnetic resonance imaging (MRI) demonstrated strikingly increased T2 signal in the corpus callosum, particularly in the splenium, and MR angiography (MRA) revealed widespread vasospasm. These abnormalities resolved on subsequent MRI studies. We diagnosed her as high altitude cerebral edema (HACE), considered to be the end stage of acute mountain sickness (AMS).
Subject(s)
Altitude Sickness/complications , Vasospasm, Intracranial/complications , Adult , Female , Humans , Magnetic Resonance Angiography/methods , Magnetic Resonance Imaging/methods , Radiography , Vasospasm, Intracranial/diagnostic imagingABSTRACT
After an episode of vasodilator-induced systemic hypotension, a 75-year-old man developed ocular lateropulsion to the right, left-side-dominant quadriparesis, loss of superficial sensation below C4 dermatome level, and anuresis. Magnetic resonance imaging (MRI) showed infarcts in the right cerebellar hemisphere (posterior inferior cerebellar artery territory) and the upper cervical cord (anterior spinal artery territory); the combination of posterior inferior cerebellar artery (PICA) and anterior spinal artery (ASA) infarcts has not been reported previously. Angiography revealed severe stenosis in the bilateral vertebral arteries. Hemodynamic hypoperfusion of the stenotic vertebral arteries may cause this unusual combination.
